Global Antimicrobial Susceptibility Testing System Market Size By Type (Antibacterial Testing, Antifungal Testing), By Application (Clinical Diagnostics, Drug Discovery and Development), By Region, An...

The Global Antimicrobial Susceptibility Testing (AST) System Market was valued at USD 3.9 billion in 2023 and is projected to surpass USD 7.1 billion by 2031, expanding at a CAGR of 7.6% during the forecast period (2023–2031). The rise in multidrug-resistant organisms, increasing global antibiotic resistance, and the growing need for precise and timely diagnostics in infectious diseases are key factors driving the market. AST systems play a pivotal role in guiding antimicrobial therapy by identifying the most effective treatment options for bacterial infections, significantly improving patient outcomes and supporting antimicrobial stewardship programs.

Drivers:

1. Rising Incidence of Antibiotic-Resistant Infections:

The global surge in antimicrobial resistance (AMR) has intensified the need for reliable susceptibility testing tools to identify resistant strains and prevent the misuse of antibiotics.

2. Growing Demand for Rapid and Automated Diagnostic Tools:

With the increasing emphasis on early diagnosis and personalized treatment, there is a strong demand for rapid, automated AST systems that provide quicker and more accurate results.

3. Supportive Government and Regulatory Initiatives:

Governments and health organizations worldwide are investing in diagnostic technologies and surveillance programs to curb AMR, driving market growth.

Restraints:

1. High Cost of AST Systems and Consumables:

The initial cost and maintenance of automated AST instruments, along with ongoing reagent expenses, pose challenges for smaller healthcare facilities and laboratories in developing regions.

2. Limited Access in Low-Resource Settings:

Despite the critical need for AST in low- and middle-income countries, limited laboratory infrastructure and insufficient funding impede market penetration in these areas.

Opportunity:

1. Advancements in Molecular AST Technologies:

Ongoing R&D is paving the way for next-generation susceptibility testing platforms that integrate genomic and proteomic tools, offering faster detection of resistance genes.

2. Growing Adoption of Point-of-Care Testing (POCT):

The miniaturization and portability of AST systems open new opportunities in decentralized testing environments such as urgent care centers and outpatient clinics.

3. Expanding Application in Veterinary Medicine and Agriculture:

The use of AST in livestock health management and food safety is gaining attention as part of a broader One Health strategy to combat AMR.

Market by System Type Insights:

In 2023, Automated AST Systems accounted for the largest market share, driven by their efficiency, accuracy, and ability to handle high sample volumes in hospital laboratories. These systems are expected to maintain dominance through 2031 as healthcare providers increasingly prefer streamlined and high-throughput diagnostic solutions. Manual AST methods are still widely used in resource-limited settings but are expected to grow at a slower pace due to longer turnaround times and labor-intensive processes.

Market by End-use Insights:

Hospitals and Diagnostic Laboratories were the leading end-users in 2023, holding more than 60% of the market. The high patient inflow and need for rapid microbial identification contribute to sustained demand in this segment. Pharmaceutical and biotechnology companies are also emerging as significant users due to their involvement in antimicrobial drug development and clinical trials.

Market by Regional Insights:

North America dominated the market in 2023, supported by a well-established healthcare infrastructure, high prevalence of AMR, and strong regulatory frameworks promoting diagnostic stewardship. Asia-Pacific is projected to experience the highest CAGR during the forecast period, driven by increasing healthcare investments, rising awareness of AMR, and expanding laboratory capacity in countries like China and India.

Competitive Scenario:

Prominent players in the Global Antimicrobial Susceptibility Testing System Market include bioMérieux SA, BD (Becton, Dickinson and Company), Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Liofilchem Srl, Merck KGaA, and Accelerate Diagnostics Inc. Key strategies among these players include technological innovation, global distribution partnerships, and product portfolio expansion to strengthen their market presence.

Scope of Work – Global Antimicrobial Susceptibility Testing System Market

Report Metric Details

Market Size (2023) USD 3.9 billion

Projected Market Size (2031) USD 7.1 billion

CAGR (2023–2031) 7.6%

Market Segments By System Type (Automated, Manual), By End-use (Hospitals, Diagnostic Labs, Pharma/Biotech)

Growth Drivers Rising AMR prevalence, automation in diagnostics, regulatory support

Opportunities Molecular AST advancements, POCT growth, One Health initiatives

Key Market Developments:

March 2023: BD launched a next-gen automated AST platform with enhanced software for real-time result reporting.

August 2023: Thermo Fisher introduced a molecular-based AST panel designed to detect resistance genes within hours.

January 2024: bioMérieux partnered with a major healthcare provider to expand AST testing services across Asia-Pacific hospitals.

FAQs:

1) What is the current market size of the Antimicrobial Susceptibility Testing System Market?

The market was valued at USD 3.9 billion in 2023.

2) What is the major growth driver of the Antimicrobial Susceptibility Testing System Market?

The rising incidence of antimicrobial resistance (AMR) is the key growth driver.

3) Which is the largest region during the forecast period in the Antimicrobial Susceptibility Testing System Market?

North America holds the largest market share, while Asia-Pacific is the fastest growing.

4) Which segment accounted for the largest market share in the Antimicrobial Susceptibility Testing System Market?

The Automated AST Systems segment accounted for the largest market share in 2023.

5) Who are the key market players in the Antimicrobial Susceptibility Testing System Market?

Key players include BD, bioMérieux, Thermo Fisher Scientific, Bio-Rad, and Liofilchem.

Let me know if you’d like this formatted for a brochure, slide deck, or web content!